Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 1 (2006), Issue 5 (May)

1. Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil.
   Braz J Med Biol Res, 39(5): 595-602. [Abstract] [Full-text]
2. Effects of heat shock protein gp96 on human dendritic cell maturation and CTL expansion.
   Biochem Biophys Res Commun, 344(2): 581-7. [Abstract] [Full-text]
3. Hepatitis C virus infection in a resident elderly population: a 10-year follow-up study.
   Dig Liver Dis, 38(5): 336-40. [Abstract] [Full-text]
4. Self-reported hepatitis and non-Hodgkin lymphoma: an analysis according to the time since hepatitis diagnosis.
   Ann Epidemiol, 16(5): 400-5. [Abstract] [Full-text]
5. Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis.
   Dig Liver Dis, 38(5): 352-4. [Abstract] [Full-text]
6. Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection.
   Clin Infect Dis, 42(11): 1536-43. [Abstract] [Full-text]
7. Long-term protection against carriage of hepatitis B virus after infant vaccination.
   J Infect Dis, 193(11): 1528-35. [Abstract] [Full-text]
8. Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users.
   J Acquir Immune Defic Syndr, 41(4): 471-6. [Abstract] [Full-text]
9. HIV/hepatitis C virus-coinfected patients with normal alanine aminotransferase levels.
   J Acquir Immune Defic Syndr, 41(5): 582-9. [Abstract] [Full-text]
10. Full genome sequence and analysis of Indian swine hepatitis E virus isolate of genotype 4.
    Vet Microbiol, 114(3): 240-51. [Abstract] [Full-text]
11. An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment.
    Addiction, 101(5): 726-30. [Abstract] [Full-text]
12. Current issues and future directions in treatment.
    Semin Liver Dis, 26(2): 192-7. [Abstract] [Full-text]
13. Small animal model systems for studying hepatitis B virus replication and pathogenesis.
    Semin Liver Dis, 26(2): 181-91. [Abstract] [Full-text]
14. In vitro models for studying hepatitis B virus drug resistance.
    Semin Liver Dis, 26(2): 171-80. [Abstract] [Full-text]
15. Antiviral drug resistance: clinical consequences and molecular aspects.
    Semin Liver Dis, 26(2): 162-70. [Abstract] [Full-text]
16. Hepatocellular carcinoma and hepatitis B virus.
    Semin Liver Dis, 26(2): 153-61. [Abstract] [Full-text]
17. Hepatitis B virus-related cirrhosis: natural history and treatment.
    Semin Liver Dis, 26(2): 142-52. [Abstract] [Full-text]
18. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment.
    Semin Liver Dis, 26(2): 130-41. [Abstract] [Full-text]
19. Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment.
    Semin Liver Dis, 26(2): 116-29. [Abstract] [Full-text]
20. Immunopathogenesis: role of innate and adaptive immune responses.
    Semin Liver Dis, 26(2): 104-15. [Abstract] [Full-text]
21. Serological and molecular diagnosis.
    Semin Liver Dis, 26(2): 97-103. [Abstract] [Full-text]
22. Hepatitis B virus: molecular virology and common mutants.
    Semin Liver Dis, 26(2): 87-96. [Abstract] [Full-text]
23. Hepatitis C virus infection among homeless men referred from a community clinic.
    West J Nurs Res, 28(4): 475-88. [Abstract] [Full-text]
24. Plasma and liver hepatitis C virus variability in patients coinfected with human immunodeficiency virus.
    J Clin Microbiol, 44(5): 1877-80. [Abstract] [Full-text]
25. Detection of hepatitis C virus antibodies and RNA among medicolegal autopsy cases in Northern France.
    Diagn Microbiol Infect Dis, 55(1): 55-8. [Abstract] [Full-text]
26. Myocarditis and heart failure associated with hepatitis C virus infection.
    J Card Fail, 12(4): 293-8. [Abstract] [Full-text]
27. Antiviral treatment of chronic hepatitis B with lamivudine in pediatric renal transplantation.
    Pediatr Transplant, 10(3): 384-9. [Abstract] [Full-text]
28. Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation.
    Pediatr Transplant, 10(3): 371-6. [Abstract] [Full-text]
29. Educational and health service needs of Australian general practitioners in managing hepatitis C.
    J Gastroenterol Hepatol, 21(4): 694-9. [Abstract] [Full-text]
30. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
    J Gastroenterol Hepatol, 21(4): 689-93. [Abstract] [Full-text]
31. Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial.
    J Gastroenterol Hepatol, 21(4): 657-63. [Abstract] [Full-text]
32. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
    Clin Gastroenterol Hepatol, 4(5): 645-52. [Abstract] [Full-text]
33. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection.
    J Hepatol, 44(6): 1026-32. [Abstract] [Full-text]
34. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.
    J Hepatol, 44(6): 1167-74. [Abstract] [Full-text]
35. Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts.
    J Hepatol, 44(6): 1089-97. [Abstract] [Full-text]
36. Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis.
    J Hepatol, 44(6): 1208-12. [Abstract] [Full-text]
37. Preventive effects of (5R)-5-hydroxytriptolide on concanavalin A-induced hepatitis.
    Eur J Pharmacol, 537(1): 181-9. [Abstract] [Full-text]
38. Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.
    Vaccine, 24(20): 4343-53. [Abstract] [Full-text]
39. The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease.
    J Hepatol, 44(6): 1175-85. [Abstract] [Full-text]
40. Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area.
    Vaccine, 24(20): 4427-32. [Abstract] [Full-text]
41. Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome.
    J Clin Endocrinol Metab, 91(5): 1741-7. [Abstract] [Full-text]
42. Short-term homing assay reveals a critical role for lymphocyte function-associated antigen-1 in the hepatic recruitment of lymphocytes in graft-versus-host disease.
    J Hepatol, 44(6): 1132-40. [Abstract] [Full-text]
43. Management of chronic hepatitis B virus infection: current perspectives for the nurse practitioner.
    J Am Acad Nurse Pract, 18(5): 203-15. [Abstract] [Full-text]
44. Systemic sarcoidosis presenting in a tattooed man undergoing treatment for hepatitis C.
    Clin Exp Dermatol, 31(3): 387-9. [Abstract] [Full-text]
45. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.
    Proteomics, 6(9): 2865-73. [Abstract] [Full-text]
46. Prevalence of hepatitis E virus infection in regular hemodialysis patients.
    Ther Apher Dial, 10(2): 193-7. [Abstract] [Full-text]
47. HIV and HCV coinfected haemophilia patients: what are the best options of orthopaedic treatment?
    Haemophilia, 12: 90-101. [Abstract] [Full-text]
48. Prevalence of hepatitis C virus infection in north-eastern Brazil: a population-based study.
    Trans R Soc Trop Med Hyg, 100(7): 663-8. [Abstract] [Full-text]
49. Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.
    Drug Alcohol Depend, 83(1): 15-24. [Abstract] [Full-text]
50. Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus.
    Transfusion, 46(5): 708-18. [Abstract] [Full-text]
51. Recent Canadian experience with targeted hepatitis C virus lookback.
    Transfusion, 46(5): 690-4. [Abstract] [Full-text]
52. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.
    Am J Transplant, 6(6): 1422-9. [Abstract] [Full-text]
53. No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data.
    Am J Transplant, 6(6): 1398-406. [Abstract] [Full-text]
54. Enlarged lymph nodes in porta hepatis: sonographic sign of chronic hepatitis B and C infections.
    J Clin Ultrasound, 34(5): 211-6. [Abstract] [Full-text]
55. Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.
    Ann Clin Microbiol Antimicrob, 5: 8. [Abstract] [Full-text]
56. Prevention of aflatoxin B1-initiated hepatotoxicity in rat by marine algae extracts.
    J Appl Toxicol, 26(3): 229-38. [Abstract] [Full-text]
57. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    AIDS, 20(8): 1171-9. [Abstract] [Full-text]
58. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.
    AIDS, 20(8): 1157-61. [Abstract] [Full-text]
59. A new subtype of hepatitis C virus genotype 1: complete genome and phylogenetic relationships of an Equatorial Guinea isolate.
    J Gen Virol, 87: 1697-702. [Abstract] [Full-text]
60. The immune response during hepatitis B virus infection.
    J Gen Virol, 87: 1439-49. [Abstract] [Full-text]
61. Post-transplant reactivation of hepatitis C virus: lymphocyte infiltration and the expression of adhesion molecules and their ligands in liver allografts.
    APMIS, 114(4): 247-54. [Abstract] [Full-text]
62. Information catastrophe in RNA viruses through replication thresholds.
    J Theor Biol, 240(3): 353-9. [Abstract] [Full-text]
63. Treatment of chronic hepatitis C in non-responsive patients with pegylated interferon associated with ribavirin and thalidomide: report of six cases of total remission.
    Rev Inst Med Trop Sao Paulo, 48(2): 109-12. [Abstract] [Full-text]
64. Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Paraná , Brazil.
    Rev Inst Med Trop Sao Paulo, 48(2): 87-92. [Abstract] [Full-text]
65. Clinical and biochemical features of autoimmune hepatitis in 36 pediatric patients.
    Arq Gastroenterol, 43(1): 45-9. [Abstract] [Full-text]
66. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection.
    Hum Immunol, 67(1): 27-32. [Abstract] [Full-text]
67. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.
    Gastroenterology, 130(6): 1679-87. [Abstract] [Full-text]
68. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
    Gastroenterology, 130(6): 1661-9. [Abstract] [Full-text]
69. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Gastroenterology, 130(6): 1636-42. [Abstract] [Full-text]
70. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients.
    Gastroenterology, 130(6): 1625-35. [Abstract] [Full-text]
71. Alcohol use and treatment of hepatitis C virus: results of a national multicenter study.
    Gastroenterology, 130(6): 1607-16. [Abstract] [Full-text]
72. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease.
    Aliment Pharmacol Ther, 23(11): 1559-66. [Abstract] [Full-text]
73. Coverage of hepatitis B vaccination in Swedish healthcare workers.
    J Hosp Infect, 63(2): 201-4. [Abstract] [Full-text]
74. Analysis of the overdispersed clock in the short-term evolution of hepatitis C virus: Using the E1/E2 gene sequences to infer infection dates in a single source outbreak.
    Mol Biol Evol, 23(6): 1242-53. [Abstract] [Full-text]
75. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up.
    Int J Cancer, 119(3): 687-94. [Abstract] [Full-text]
76. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
    Virology, 348(2): 297-308. [Abstract] [Full-text]
77. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.
    Gut, 55(6): 869-77. [Abstract] [Full-text]
78. Swine as a principal reservoir of hepatitis E virus that infects humans in eastern China.
    J Infect Dis, 193(12): 1643-9. [Abstract] [Full-text]
79. Phylogenetic analysis of hepatitis E virus isolates in southern China (1994-1998).
    J Clin Virol, 36(2): 103-10. [Abstract] [Full-text]
80. Identification of a novel variant of human hepatitis E virus in Hungary.
    J Clin Virol, 36(2): 100-2. [Abstract] [Full-text]
81. Novel approaches for therapy of chronic hepatitis C.
    J Clin Virol, 36(2): 87-94. [Abstract] [Full-text]
82. Lack of association between microsomal triglyceride transfer protein gene polymorphism and liver steatosis in HCV-infected patients.
    Mol Genet Metab, 88(2): 196-8. [Abstract] [Full-text]
83. Fatal outcome of herpes simplex virus type 1-induced necrotic hepatitis in a neonate.
    Med Microbiol Immunol, 195(2): 101-5. [Abstract] [Full-text]
84. A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods.
    Clin Infect Dis, 42(12): 1685-91. [Abstract] [Full-text]
85. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan.
    Clin Infect Dis, 42(12): 1679-84. [Abstract] [Full-text]
86. Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia.
    Clin Infect Dis, 42(12): 1674-8. [Abstract] [Full-text]
87. Acute hepatitis C virus infection in incarcerated injection drug users.
    Clin Infect Dis, 42(12): 1663-70. [Abstract] [Full-text]
88. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Am J Prev Med, 30(6): 498-506. [Abstract] [Full-text]
89. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis.
    J Gastroenterol Hepatol, 21(5): 887-93. [Abstract] [Full-text]
90. Intrafamilial prevalence of hepatitis B virus in Western Brazilian Amazon region: epidemiologic and biomolecular study.
    J Gastroenterol Hepatol, 21(5): 863-8. [Abstract] [Full-text]
91. Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B.
    J Gastroenterol Hepatol, 21(5): 859-62. [Abstract] [Full-text]
92. Sphingosine-1-phosphate receptor agonists suppress concanavalin A-induced hepatic injury in mice.
    Biochem Biophys Res Commun, 345(1): 85-92. [Abstract] [Full-text]
93. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays.
    Am J Clin Pathol, 125(5): 748-51. [Abstract] [Full-text]
94. Poor response to hepatitis C virus (HCV) therapy in HIV- and HCV-coinfected patients is not due to lower adherence to treatment.
    AIDS Res Hum Retroviruses, 22(5): 393-400. [Abstract] [Full-text]
95. Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype.
    Gene Ther, 13(11): 883-92. [Abstract] [Full-text]
96. (14)C-lidocaine disposition in serum and tissues of normal and liver diseased rats.
    J Oral Maxillofac Surg, 64(6): 892-5. [Abstract] [Full-text]
97. Propylthiouracil-associated liver failure presenting as probable autoimmune hepatitis in a child with Graves' disease.
    Pediatr Transplant, 10(4): 525-8. [Abstract] [Full-text]
98. Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation.
    Pediatr Transplant, 10(4): 479-86. [Abstract] [Full-text]
99. Hepatitis B vaccination is effective for babies weighing less than 1800 g.
    J Paediatr Child Health, 42(5): 268-76. [Abstract] [Full-text]
100. Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial.
     Am J Gastroenterol, 101(5): 983-92. [Abstract] [Full-text]
101. Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance.
     J Subst Abuse Treat, 30(4): 331-5. [Abstract] [Full-text]
102. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network.
     J Subst Abuse Treat, 30(4): 315-21. [Abstract] [Full-text]
103. Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra.
     J Virol Methods, 135(1): 109-17. [Abstract] [Full-text]
104. Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C.
     Blood, 107(11): 4424-32. [Abstract] [Full-text]
105. Antiviral options for the treatment of chronic hepatitis B.
     J Antimicrob Chemother, 57(6): 1030-4. [Abstract] [Full-text]
106. Protective immunity against hepatitis C virus infection.
     Immunol Cell Biol, 84(3): 239-49. [Abstract] [Full-text]
107. Hepatitis delta virus infection in chronically HBV-infected patients from northern Poland.
     Arch Virol, 151(6): 1207-15. [Abstract] [Full-text]
108. Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease.
     Histopathology, 48(7): 822-30. [Abstract] [Full-text]
109. Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area.
     Oncogene, 25(22): 3219-24. [Abstract] [Full-text]
110. Drug-induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long-acting repeatable attributed to the use of pegvisomant.
     Eur J Endocrinol, 154(6): 805-6. [Abstract] [Full-text]
111. Changing prevalence, clinical features, and outcome of acute hepatitis in Spain (1982-2003).
     J Gastroenterol Hepatol, 21(6): 982-7. [Abstract] [Full-text]
112. Hepatitis B core antigen expression pattern reflects the response to anti-viral treatment.
     J Gastroenterol Hepatol, 21(6): 977-81. [Abstract] [Full-text]
113. Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2).
     J Gastroenterol Hepatol, 21(6): 970-6. [Abstract] [Full-text]
114. Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft.
     Liver Transpl, 12(6): 993-7. [Abstract] [Full-text]
115. Differential promoter usage for insulin-like growth factor-II gene in Chinese hepatocellular carcinoma with hepatitis B virus infection.
     Cancer Detect Prev, 30(2): 192-203. [Abstract] [Full-text]
116. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
     Virus Res, 119(2): 146-53. [Abstract] [Full-text]
117. Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy.
     Intern Med J, 36(6): 362-6. [Abstract] [Full-text]
118. Alanine transaminase levels in the year before pregnancy predict the risk of hepatitis C virus vertical transmission.
     J Med Virol, 78(7): 911-4. [Abstract] [Full-text]
119. Emergence and takeover of precore-stop mutant prior to exacerbation of e antigen-negative chronic hepatitis B after withdrawal of lamivudine therapy.
     J Med Virol, 78(7): 906-10. [Abstract] [Full-text]
120. Long-term follow-up of hepatitis B carrier children treated with interferon and prednisolone.
     J Med Virol, 78(7): 888-95. [Abstract] [Full-text]
121. Impact of obesity on treatment of chronic hepatitis C.
     Hepatology, 43(6): 1177-86. [Abstract] [Full-text]
122. Hepatitis C vaccines: Inducing and challenging memory T cells.
     Hepatology, 43(6): 1395-8. [Abstract] [Full-text]
123. Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application.
     Hepatology, 43(6): 1346-53. [Abstract] [Full-text]
124. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
     Hepatology, 43(6): 1337-45. [Abstract] [Full-text]
125. Step-by-step progress toward understanding the hepatitis C virus RNA helicase.
     Hepatology, 43(6): 1392-5. [Abstract] [Full-text]
126. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.
     Hepatology, 43(6): 1385-91. [Abstract] [Full-text]
127. Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam.
     Hepatology, 43(6): 1375-84. [Abstract] [Full-text]
128. Keratin variants associate with progression of fibrosis during chronic hepatitis C infection.
     Hepatology, 43(6): 1354-63. [Abstract] [Full-text]
129. Host cell responses induced by hepatitis C virus binding.
     Hepatology, 43(6): 1326-36. [Abstract] [Full-text]
130. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
     Hepatology, 43(6): 1317-25. [Abstract] [Full-text]
131. Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection.
     Hepatology, 43(6): 1311-6. [Abstract] [Full-text]
132. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
     Hepatology, 43(6): 1211-9. [Abstract] [Full-text]
133. Neutrophil depletion protects against murine acetaminophen hepatotoxicity.
     Hepatology, 43(6): 1220-30. [Abstract] [Full-text]
134. Disruption of NaS1 sulfate transport function in mice leads to enhanced acetaminophen-induced hepatotoxicity.
     Hepatology, 43(6): 1241-7. [Abstract] [Full-text]
135. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients.
     Hepatology, 43(6): 1303-10. [Abstract] [Full-text]
136. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
     Hepatology, 43(6): 1295-302. [Abstract] [Full-text]
137. Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively.
     Proc Natl Acad Sci U S A, 103(22): 8475-80. [Abstract] [Full-text]
138. Role of HCV coinfection towards disease progression and survival in HIV-1 infected children: a follow-up study of 10 years.
     J Trop Pediatr, 52(3): 206-11. [Abstract] [Full-text]
139. Mass needle stick injury in children from the Western cape.
     J Trop Pediatr, 52(3): 192-6. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.